APA (7th ed.) Citation

Mohamed, M. F., Qian, Y., D'Cunha, R., Sligh, T., Ferris, L. K., Eldred, A., . . . Carcereri De Prati, R. (2024). Pharmacokinetics, safety, and efficacy of cedirogant from phase I studies in healthy participants and patients with chronic plaque psoriasis. CTS: Clinical & Translational Science, 17(1), 1. https://doi.org/10.1111/cts.13682

Chicago Style (17th ed.) Citation

Mohamed, Mohamed‐Eslam F., et al. "Pharmacokinetics, Safety, and Efficacy of Cedirogant from Phase I Studies in Healthy Participants and Patients with Chronic Plaque Psoriasis." CTS: Clinical & Translational Science 17, no. 1 (2024): 1. https://doi.org/10.1111/cts.13682.

MLA (9th ed.) Citation

Mohamed, Mohamed‐Eslam F., et al. "Pharmacokinetics, Safety, and Efficacy of Cedirogant from Phase I Studies in Healthy Participants and Patients with Chronic Plaque Psoriasis." CTS: Clinical & Translational Science, vol. 17, no. 1, 2024, p. 1, https://doi.org/10.1111/cts.13682.